Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-17
2010-11-23
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S268000, C548S453000
Reexamination Certificate
active
07838528
ABSTRACT:
Compounds for the treatment of elevated blood glucose levels and the physiological and metabolic disorders arising therefrom are disclosed and comprise novel substituted bicyclic 8-pyrrolidinoxanthines and their derivatives of formula I:wherein the various R groups are hereinafter defined. The present invention also comprises pharmaceutical compositions comprising them as well as processes for the preparation of these compounds. Particular blood glucose disorders treatable thereby include type-2 diabetes, insulin resistance, hyperglycemia, arteriosclerotic diseases and the like.
REFERENCES:
patent: 3472861 (1969-10-01), Schulz et al.
patent: 7074798 (2006-07-01), Yoshikawa et al.
patent: 7235538 (2007-06-01), Kanstrup et al.
patent: 7495004 (2009-02-01), Boggs et al.
patent: 2004/0087587 (2004-05-01), Himmelsbach et al.
patent: 2007/0197563 (2007-08-01), Schoenafinger et al.
patent: 1338595 (2003-10-01), None
patent: 00063208 (2000-10-01), None
patent: 02/068420 (2002-09-01), None
Biandine Laferrere et al., Effects of bombesin, of new bombesin agonist (BIM187) and a new antagonist (BIM189) on food intake in rats, in relation to cholecystokinin, European Journal of Pharmacology, 1992, vol. 215, pp. 23-28.
Corri Black et al., Meglitinide analogues for type 2 diabetes meilitus , The Cochrane Review, (2007).
Renzo Cescato et al., Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting, The Journal of Nuclear Medicine, 2008, vol. 49, No.2, pp. 318-326.
Buning Christian
Defossa Elisabeth
Jaehne Gerhard
Schoenafinger Karl
Schwink Lothar
Berch Mark L
Farquharson-Torres Serena
sanofi-aventis Deutschland GmbH
LandOfFree
Substituted bicyclic 8-pyrrolidinoxanthines, methods for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted bicyclic 8-pyrrolidinoxanthines, methods for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted bicyclic 8-pyrrolidinoxanthines, methods for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4155473